Sarcoma treatment in the era of molecular medicine.

Grünewald TG, Alonso M, Avnet S, Banito A, Burdach S, Cidre-Aranaz F, Di Pompo G, Distel M, Dorado-Garcia H, Garcia-Castro J, González-González L, Grigoriadis AE, Kasan M, Koelsche C, Krumbholz M, Lecanda F, Lemma S, Longo DL, Madrigal-Esquivel C, Morales-Molina Á, Musa J, Ohmura S, Ory B, Pereira-Silva M, Perut F, Rodriguez R, Seeling C, Al Shaaili N, Shaabani S, Shiavone K, Sinha S, Tomazou EM, Trautmann M, Vela M, Versleijen-Jonkers YM, Visgauss J, Zalacain M, Schober SJ, Lissat A, English WR, Baldini N, Heymann D

Open source

DOI
10.15252/emmm.201911131
Published
2020 Nov 6
Container
EMBO molecular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15252/emmm.201911131,
  title = {Sarcoma treatment in the era of molecular medicine.},
  author = {Grünewald TG and Alonso M and Avnet S and Banito A and Burdach S and Cidre-Aranaz F and Di Pompo G and Distel M and Dorado-Garcia H and Garcia-Castro J and González-González L and Grigoriadis AE and Kasan M and Koelsche C and Krumbholz M and Lecanda F and Lemma S and Longo DL and Madrigal-Esquivel C and Morales-Molina Á and Musa J and Ohmura S and Ory B and Pereira-Silva M and Perut F and Rodriguez R and Seeling C and Al Shaaili N and Shaabani S and Shiavone K and Sinha S and Tomazou EM and Trautmann M and Vela M and Versleijen-Jonkers YM and Visgauss J and Zalacain M and Schober SJ and Lissat A and English WR and Baldini N and Heymann D},
  year = {2020},
  journal = {EMBO molecular medicine},
  doi = {10.15252/emmm.201911131},
  url = {https://doi.org/10.15252/emmm.201911131}
}

RIS

TY  - JOUR
TI  - Sarcoma treatment in the era of molecular medicine.
AU  - Grünewald TG
AU  - Alonso M
AU  - Avnet S
AU  - Banito A
AU  - Burdach S
AU  - Cidre-Aranaz F
AU  - Di Pompo G
AU  - Distel M
AU  - Dorado-Garcia H
AU  - Garcia-Castro J
AU  - González-González L
AU  - Grigoriadis AE
AU  - Kasan M
AU  - Koelsche C
AU  - Krumbholz M
AU  - Lecanda F
AU  - Lemma S
AU  - Longo DL
AU  - Madrigal-Esquivel C
AU  - Morales-Molina Á
AU  - Musa J
AU  - Ohmura S
AU  - Ory B
AU  - Pereira-Silva M
AU  - Perut F
AU  - Rodriguez R
AU  - Seeling C
AU  - Al Shaaili N
AU  - Shaabani S
AU  - Shiavone K
AU  - Sinha S
AU  - Tomazou EM
AU  - Trautmann M
AU  - Vela M
AU  - Versleijen-Jonkers YM
AU  - Visgauss J
AU  - Zalacain M
AU  - Schober SJ
AU  - Lissat A
AU  - English WR
AU  - Baldini N
AU  - Heymann D
PY  - 2020
JO  - EMBO molecular medicine
DO  - 10.15252/emmm.201911131
UR  - https://doi.org/10.15252/emmm.201911131
ER  - 

APA

TG, G., M, A., S, A., A, B., S, B., F, C., G, D. P., M, D., H, D., J, G., L, G., AE, G., M, K., C, K., M, K., F, L., S, L., DL, L., C, M., Á, M., J, M., S, O., B, O., M, P., F, P., R, R., C, S., N, A. S., S, S., K, S., S, S., EM, T., M, T., M, V., YM, V., J, V., M, Z., SJ, S., A, L., WR, E., N, B., & D, H. (2020). Sarcoma treatment in the era of molecular medicine.. EMBO molecular medicine. https://doi.org/10.15252/emmm.201911131

Source records